Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ASC. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107011354B reveals a high-purity AgNO3/SOCl2 nitration route for 5-ISMN, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1028361C details asymmetric synthesis of 2(S)-glutaric acid intermediates, offering high purity and scalable routes for cardiovascular drug manufacturing.
Advanced process for Factor Xa inhibitor intermediates via 1,3-dipolar cycloaddition. Ensures high purity, scalable manufacturing, and cost-effective supply chain solutions.
Advanced synthesis of 5-amino-3-cyano-1-((2,6-dichloro-4-trifluoromethyl) phenyl)-1H-pyrazole via patent CN101693691B. High yield, scalable agrochemical intermediate manufacturing with cost efficiency.
Novel resolution process for high-purity beraprost acid via diastereomeric esterification. Reduces manufacturing costs and ensures supply chain stability for pharmaceutical intermediates.
Patent CN1218454A reveals a superior catalytic reduction process for ACE inhibitor intermediates, offering high yield, minimized impurities, and scalable manufacturing for pharmaceutical supply chains.
Novel Weinreb amide route for Treprostinil intermediates eliminates heavy metals and cryogenic conditions, ensuring high purity and scalable manufacturing for pulmonary hypertension therapies.
Patent CN119080882A reveals a green TAPS method for eptifibatide derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel synthesis route for oxadiazole compound offers high purity and simplified purification for reliable pharmaceutical intermediate supply chains globally.
Novel solid-state route for Milrinone intermediate reduces toxicity and improves yield. Ideal for scalable API manufacturing and cost reduction.
Discover a breakthrough Milrinone synthesis route offering >90% yield and superior purity. Ideal for pharmaceutical manufacturers seeking cost-effective, scalable API intermediates.
Discover advanced synthesis routes for beta-alanine derivatives per CN1329595A. Enhance supply chain stability and reduce manufacturing costs for cardiovascular API intermediates.
Novel seven-step route for AHU-377 intermediates reduces costs and improves scalability for heart failure drug production supply chains globally
Patent CN105152887A reveals high-yield beta-damascenone production. Enhances supply chain stability and reduces manufacturing costs for global fragrance buyers.
Discover advanced biocatalytic synthesis for ticagrelor intermediates using engineered ketoreductase. Achieve high substrate loading and cost reduction in pharmaceutical manufacturing.
Patent CN102001920A details a scalable POBr3 method for Aliskiren intermediates, eliminating column chromatography for significant cost reduction and supply chain reliability.
Patent CN113308443B reveals a mutant monooxygenase boosting azaphilone yield to 92.8%. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Patent CN113005162A reveals a novel enzymatic route for NMN. Discover cost-effective, scalable production methods for high-purity nutritional ingredients.
Novel metal-free synthesis of thienoquinolinone intermediates disclosed in patent CN103951676A. High yield, scalable process for pharmaceutical R&D and supply chain optimization.
Patent CN105418567B enables high-purity beraprost production. Discover cost-effective, scalable routes for pharmaceutical intermediates and supply chain optimization.